General Range

FORDOXIME-200

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FORDOXIME-200 Dispersible Tablets by Fortune Labs contain Cefpodoxime Proxetil 200 mg, a third-generation cephalosporin antibiotic used to treat various susceptible bacterial infections. This medicine works by inhibiting bacterial cell wall synthesis, helping eliminate infection-causing bacteria. FORDOXIME-200 may be prescribed for respiratory tract infections, throat infections, sinusitis, urinary tract infections, and certain skin infections when clinically appropriate. Its dispersible tablet formulation offers a convenient administration option as directed by a healthcare professional. Available in 10 × 10 tablet blister packaging, FORDOXIME-200 is part of Fortune Labs' pharmaceutical product portfolio. Fortune Labs offers PCD Pharma Franchise and distribution opportunities across India. Contact the company for product availability, wholesale pricing, monopoly rights, and franchise enquiries. Use only with a valid prescription.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Cefpodoxime Proxetil 200 mg
Packaging Type: Blister Pack
Packaging Size: 10 × 10
Dosage Form: Tablet
Treatment: Bacterial respiratory tract infections, throat infections, sinusitis, ear infections, urinary tract infections, and certain skin infections.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?